resveratrol has been researched along with Fatty Liver in 43 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (13.95) | 29.6817 |
| 2010's | 31 (72.09) | 24.3611 |
| 2020's | 6 (13.95) | 2.80 |
| Authors | Studies |
|---|---|
| Fernández-Quintela, A; Hernández, F; Izquierdo-Sandoval, D; Lacalle-Bergeron, L; Portillo, MP; Portolés, T; Sancho, JV | 1 |
| Cui, X; Guo, X; Miao, X; Su, F; Ye, H | 1 |
| Cao, H; Hu, G; Li, G; Wang, X; Xing, C; Yang, F; Zhang, C; Zhou, S | 1 |
| Cao, H; Dai, X; Hu, G; Liu, P; Luo, J; Wang, Y; Xing, C; Yang, F; Zhang, C | 1 |
| Chen, F; Hu, X; Ke, W; Li, D; Wang, J; Wang, P | 1 |
| Biasutto, L; Bujanda, L; Fernández-Quintela, A; Gómez-Zorita, S; Lasa, A; Macarulla, MT; Milton-Laskibar, I; Miranda, J; Portillo, MP; Segues, N | 1 |
| Eseberri, I; Fernández-Quintela, A; González, M; Gracia, A; Miranda, J; Portillo, MP | 1 |
| Di Giacomo, M; Ferramosca, A; Zara, V | 1 |
| Aguirre, L; Fernández-Quintela, A; Milton-Laskibar, I; Palmeira, CM; Portillo, MP; Rolo, AP; Soeiro Teodoro, J | 1 |
| Abdel-Aleem, GA; Khaleel, EF; Mostafa, DG | 1 |
| Akter, J; An, HJ; Chun, P; Chung, HY; Jeong, HO; Kim, DH; Kim, MJ; Kim, SJ; Lee, B; Lee, EK; Lee, HJ; Moon, HR; Moon, KM; Ullah, S; Yang, J | 1 |
| Aguirre, L; Etxeberria, U; Martínez, JA; Milagro, FI; Milton-Laskibar, I; Portillo, MP | 1 |
| Eseberri, I; Fernández-Quintela, A; Gómez-Zorita, S; González, M; Milton-Laskibar, I; Portillo, MP; Trepiana, J | 1 |
| Cheng, K; Li, S; Song, Z; Wang, C; Wang, T; Zhang, H; Zhang, L | 1 |
| Hu, T; Jing, Y; Lin, C; Liu, F; Wang, R; Xiong, Q; Yuan, J; Zhao, X | 1 |
| Gao, M; Liu, D | 1 |
| Alpaslan, N; Gül, M; Talu, MF; Yiğitcan, B | 1 |
| Benkdane, M; Bonnafous, S; Gual, P; Lafdil, F; Lotersztajn, S; Louvet, A; Mallat, A; Pavoine, C; Pecker, F; Teixeira-Clerc, F; Tran, A; Wan, J | 1 |
| Hai, J; Li, K; Li, L; Li, Z; Peng, H; Weng, X; Zhang, Y | 1 |
| Ding, WX; Du, K; Ni, HM; You, M | 1 |
| Ho, CT; Lai, CS; Pan, MH; Tsai, ML | 1 |
| Bica, CG; da Silva, VD; Dora, CL; Hadrich, G; Klein, CP; Lopes, TG; Morrone, FB; Nicoletti, NF; Schwingel, TE | 1 |
| Cho, SJ; Choi, MS; Jung, UJ; Kim, HJ; Moon, BS; Park, HJ | 1 |
| Adibi, P; Faghihzadeh, F; Hekmatdoost, A; Rafiei, R | 1 |
| Akao, M; Fujiwara, Y; Hiroi, S; Iwaya, K; Kinoshita, M; Nishikawa, K; Sakamoto, T; Seki, S; Sonoda, M; Suzuki, T; Thiruppathi, S | 1 |
| Adibi, P; Faghihzadeh, F; Hekmatdoost, A | 1 |
| Chen, LL; Shang, J; Xiao, FX | 1 |
| Aldazabal, P; Arenas, JI; Beraza, M; Bujanda, L; Cosme, A; García-Urkia, N; González, A; Hijona, E; Irastorza, B; Larzabal, M; Sarasqueta, C | 1 |
| Ahn, J; Cho, I; Ha, T; Kim, S; Kwon, D | 1 |
| Fang, SR; Feng, YQ; Fu, YC; Wang, GL; Xu, WC; Zhou, XH | 1 |
| Akamine, A; Hashiguchi, I; Ike, A; Ishida, T; Ishii, Y; Koga, T; Kuramoto, C; Takeda, T; Taketoh, J; Yahata, M; Yamada, H | 1 |
| Cogger, VC; Desbiens, M; Garand, C; Labbé, A; Le Couteur, DG; Lebel, M; Paquet, ER | 1 |
| Aguirre, L; Bujanda, L; Fernández-Quintela, A; Gómez-Zorita, S; Hijona, E; Macarulla, MT; Martínez, JA; Milagro, F; Portillo, MP | 1 |
| Cho, GJ; Choi, WS; Jeon, BT; Jeong, EA; Kang, SS; Kim, HJ; Lee, DH; Lee, Y; Roh, GS; Shin, HJ | 1 |
| Cho, SJ; Choi, MS; Jung, UJ | 1 |
| Chen, YF; Hsu, WH; Kao, CH; Lin, HC; Tsai, TF; Yang, CW | 1 |
| Bao, S; Fan, Z; Jia, W; Li, H; Liao, W; Qiu, Y; Wang, K; Wang, S; Xie, G; Yang, H; Yang, Y; Zhang, Y; Zhao, A; Zhao, L; Zhou, M | 1 |
| Cao, X; Dong, W; Gu, Y; Jiang, L; Li, F; Li, Q; Liu, F; Wang, C; Wang, H; Wang, J; Xu, Y; Ye, J; Zhang, L; Zhao, Y | 1 |
| Amaral, TA; Franco, JG; Lima, NS; Lisboa, PC; Moura, EG; Oliveira, E; Passos, MC; Peixoto-Silva, N; Resende, AC | 1 |
| Hu, PZ; Li, J; Li, L; Li, ZS; Wang, C; Ye, J; Yuan, Y; Zhang, XM | 1 |
| Clasen, BF; Hamilton-Dutoit, S; Jessen, N; Kjær, TN; Larsen, JØ; Paulsen, SK; Pedersen, SB; Poulsen, MM; Richelsen, B | 1 |
| Cui, W; Gao, D; Han, H; Hao, L; Sun, X; Xin, P; Yang, X; Ying, C | 1 |
| Chen, LL; Ding, HC; Shang, J; Sun, H; Xiao, FX; Xiao, H | 1 |
3 review(s) available for resveratrol and Fatty Liver
| Article | Year |
|---|---|
Antioxidant dietary approach in treatment of fatty liver: New insights and updates.
Topics: Animals; Anthocyanins; Antioxidants; Carotenoids; Catechin; Coumestrol; Curcumin; Energy Metabolism; Fatty Liver; Glucosinolates; Humans; Imidoesters; Isothiocyanates; Lipogenesis; Mitochondria; Non-alcoholic Fatty Liver Disease; Nutritional Sciences; Oxidative Stress; Oximes; Polyphenols; Quercetin; Resveratrol; Stilbenes; Sulfoxides; Xanthophylls | 2017 |
Involvement of 5'-Activated Protein Kinase (AMPK) in the Effects of Resveratrol on Liver Steatosis.
Topics: AMP-Activated Protein Kinases; Animals; Fatty Liver; Humans; Models, Biological; Resveratrol | 2018 |
Chemoprevention of nonalcoholic fatty liver disease by dietary natural compounds.
Topics: Adipokines; Animals; Carotenoids; Curcumin; Fatty Acids, Omega-3; Fatty Liver; Flavonols; Humans; Insulin Resistance; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress; Polyphenols; Resveratrol; Stilbenes | 2014 |
3 trial(s) available for resveratrol and Fatty Liver
| Article | Year |
|---|---|
Abnormal expression of liver autophagy and apoptosis-related mRNA in fatty liver haemorrhagic syndrome and improvement function of resveratrol in laying hens.
Topics: Animal Feed; Animals; Chickens; Diet; Dietary Proteins; Energy Intake; Fatty Liver; Female; Hemorrhage; Liver; Oviposition; Poultry Diseases; Resveratrol; RNA, Messenger | 2020 |
Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease.
Topics: Adult; Alanine Transaminase; Anthropometry; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Cytokines; Diet; Dietary Supplements; Double-Blind Method; Exercise; Fatty Liver; Female; Humans; Inflammation Mediators; Keratin-18; Liver; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Phytotherapy; Plant Extracts; Polyphenols; Resveratrol; Stilbenes | 2014 |
The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.
Topics: Adult; Alanine Transaminase; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Blood Pressure; Cardiovascular Diseases; Dietary Supplements; Double-Blind Method; Fatty Liver; Female; Humans; Insulin Resistance; Lipid Metabolism; Liver; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Phytotherapy; Plant Extracts; Resveratrol; Risk Factors; Stilbenes; Triglycerides | 2015 |
37 other study(ies) available for resveratrol and Fatty Liver
| Article | Year |
|---|---|
LC-IMS-HRMS for identification of biomarkers in untargeted metabolomics: The effects of pterostilbene and resveratrol consumption in liver steatosis, animal model.
Topics: Animals; Biomarkers; Fatty Liver; Models, Animal; Rats; Rats, Wistar; Resveratrol | 2023 |
Resveratrol attenuates efavirenz-induced hepatic steatosis and hypercholesterolemia in mice by inhibiting pregnane X receptor activation and decreasing inflammation.
Topics: Animals; Cholesterol; Fatty Liver; Hypercholesterolemia; Inflammation; Male; Mice; Pregnane X Receptor; Resveratrol | 2023 |
The protective effects of resveratrol on antioxidant function and the mRNA expression of inflammatory cytokines in the ovaries of hens with fatty liver hemorrhagic syndrome.
Topics: Animals; Antioxidants; Avian Proteins; Chickens; Cytokines; Fatty Liver; Female; Gene Expression; Hemorrhage; Ovary; Oxidation-Reduction; Protective Agents; Reproduction; Resveratrol; RNA, Messenger | 2020 |
Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis.
Topics: Animals; Antioxidants; Bacteroides; Body Weight; Clostridiales; Diet, High-Fat; Fatty Liver; Firmicutes; Gastrointestinal Microbiome; Inflammation; Insulin Resistance; Intestinal Mucosa; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity; Resveratrol | 2020 |
Pterostilbene modifies triglyceride metabolism in hepatic steatosis induced by high-fat high-fructose feeding: a comparison with its analog resveratrol.
Topics: Adipose Tissue; Animals; Diet, High-Fat; Disease Models, Animal; Fatty Liver; Fructose; Lipids; Lipogenesis; Liver; Male; Rats; Rats, Wistar; Resveratrol; Stilbenes; Triglycerides | 2021 |
Are miRNA-103, miRNA-107 and miRNA-122 Involved in the Prevention of Liver Steatosis Induced by Resveratrol?
Topics: Animals; Carnitine O-Palmitoyltransferase; Cell Line; Diet, High-Fat; Down-Regulation; Fatty Acid Synthases; Fatty Liver; Hepatocytes; Liver; Male; MicroRNAs; Rats; Rats, Sprague-Dawley; Resveratrol; Sterol Regulatory Element Binding Protein 1; Stilbenes | 2017 |
Lack of Additive Effects of Resveratrol and Energy Restriction in the Treatment of Hepatic Steatosis in Rats.
Topics: Acetyl-CoA Carboxylase; Alanine Transaminase; AMP-Activated Protein Kinases; Animals; Aspartate Aminotransferases; Caloric Restriction; Coenzyme A Ligases; Diacylglycerol O-Acyltransferase; Diet, High-Fat; Fatty Acid Transport Proteins; Fatty Acids; Fatty Liver; Liver; Male; Organ Size; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; PPAR alpha; Rats; Rats, Wistar; Resveratrol; Sirtuin 1; Stilbenes; Triglycerides; Uncoupling Protein 2 | 2017 |
Resveratrol improves high-fat diet induced fatty liver and insulin resistance by concomitantly inhibiting proteolytic cleavage of sterol regulatory element-binding proteins, free fatty acid oxidation, and intestinal triglyceride absorption.
Topics: Animals; Antioxidants; Area Under Curve; Diet, High-Fat; Fatty Acids, Nonesterified; Fatty Liver; Feces; Gene Expression Regulation; Glucose; Glucose Tolerance Test; Insulin Resistance; Intestinal Absorption; Lipase; Liver; Male; Organ Size; Oxidation-Reduction; Oxidative Stress; Proteolysis; Rats, Wistar; Resveratrol; RNA, Messenger; Sterol Regulatory Element Binding Proteins; Stilbenes; Triglycerides | 2018 |
Novel SIRT1 activator MHY2233 improves glucose tolerance and reduces hepatic lipid accumulation in db/db mice.
Topics: Acetyl-CoA Carboxylase; Animals; Benzoxazoles; Body Weight; Diabetes Mellitus; Enzyme Activators; Fatty Acid Synthases; Fatty Liver; Gene Expression Regulation; Glucose Intolerance; Heterocyclic Compounds, 4 or More Rings; Hypoglycemic Agents; Male; Metabolic Syndrome; Mice, Inbred C57BL; Molecular Docking Simulation; Resveratrol; Sirtuin 1; Sterol Regulatory Element Binding Proteins; Stilbenes | 2018 |
Involvement of autophagy in the beneficial effects of resveratrol in hepatic steatosis treatment. A comparison with energy restriction.
Topics: Animals; Autophagy; Blotting, Western; Caloric Restriction; Diet, High-Fat; Dietary Carbohydrates; Fatty Liver; Male; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Rats; Rats, Wistar; Resveratrol; Sucrose | 2018 |
The therapeutic effects of resveratrol on hepatic steatosis in high-fat diet-induced obese mice by improving oxidative stress, inflammation and lipid-related gene transcriptional expression.
Topics: Animals; Diet, High-Fat; Fatty Liver; Gene Expression; Inflammation; Insulin; Lipid Metabolism; Lipids; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress; Resveratrol; Transcription, Genetic | 2019 |
Resveratrol downregulates PCSK9 expression and attenuates steatosis through estrogen receptor α-mediated pathway in L02 cells.
Topics: Cell Line; Down-Regulation; Estrogen Receptor alpha; Fatty Acids, Nonesterified; Fatty Liver; Gene Expression Regulation, Enzymologic; Humans; Intracellular Space; Proprotein Convertase 9; Receptors, LDL; Resveratrol; RNA, Messenger; Sterol Regulatory Element Binding Protein 1; Triglycerides | 2019 |
Resveratrol suppresses T0901317-induced hepatic fat accumulation in mice.
Topics: Animals; Cells, Cultured; Fatty Liver; Hepatocytes; Hydrocarbons, Fluorinated; Liver X Receptors; Male; Mice; Mice, Inbred C57BL; Orphan Nuclear Receptors; Resveratrol; Stilbenes; Sulfonamides | 2013 |
Calculation of melatonin and resveratrol effects on steatosis hepatis using soft computing methods.
Topics: Algorithms; Animals; Computer Systems; Fatty Liver; Humans; Image Processing, Computer-Assisted; Liver; Male; Melatonin; Neural Networks, Computer; Rats; Rats, Sprague-Dawley; Resveratrol; Software; Stilbenes; Support Vector Machine | 2013 |
M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease.
Topics: Adult; Animals; Apoptosis; Arginase; Biomarkers; Diet, High-Fat; Enzyme Activation; Ethanol; Fatty Liver; Female; Humans; Interleukin-10; Kupffer Cells; Liver; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Middle Aged; Obesity, Morbid; Paracrine Communication; Resveratrol; Stilbenes | 2014 |
Resveratrol modulates autophagy and NF-κB activity in a murine model for treating non-alcoholic fatty liver disease.
Topics: Animals; Autophagy; Diet, High-Fat; Disease Models, Animal; DNA Primers; Fatty Liver; Inflammation; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Oxidative Stress; Polymerase Chain Reaction; Resveratrol; Stilbenes | 2014 |
Critical role of FoxO3a in alcohol-induced autophagy and hepatotoxicity.
Topics: Animals; Autophagy; Central Nervous System Depressants; Enzyme Inhibitors; Ethanol; Fatty Liver; Forkhead Box Protein O3; Forkhead Transcription Factors; Gene Expression Regulation; Hepatocytes; Liver; Liver Diseases, Alcoholic; Mice; Mice, Knockout; Resveratrol; Sirtuin 1; Stilbenes | 2013 |
Effects of the compounds resveratrol, rutin, quercetin, and quercetin nanoemulsion on oxaliplatin-induced hepatotoxicity and neurotoxicity in mice.
Topics: Alanine Transaminase; Animals; Antineoplastic Agents; Aspartate Aminotransferases; Caspase 3; Emulsions; Fatty Liver; Hyperalgesia; Lumbar Vertebrae; Male; Mice, Inbred BALB C; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Peroxidase; Proto-Oncogene Proteins c-fos; Quercetin; Resveratrol; Rutin; Spinal Cord; Stilbenes | 2014 |
The beneficial effects of combined grape pomace and omija fruit extracts on hyperglycemia, adiposity and hepatic steatosis in db/db mice: a comparison with major index compounds.
Topics: Adiponectin; Adiposity; Animals; Biomarkers; Blood Glucose; Cyclooctanes; Diabetes Mellitus, Experimental; Fatty Liver; Fruit; Glycated Hemoglobin; Hyperglycemia; Insulin; Leptin; Lignans; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Plant Extracts; Polycyclic Compounds; Resistin; Resveratrol; Schisandra; Stilbenes; Vitis | 2014 |
Resveratrol increases CD68⁺ Kupffer cells colocalized with adipose differentiation-related protein and ameliorates high-fat-diet-induced fatty liver in mice.
Topics: Adipose Tissue; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Diet, High-Fat; Down-Regulation; Fatty Liver; Kupffer Cells; Liver; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Organ Size; Perilipin-2; Proteomics; Resveratrol; Stilbenes; Triglycerides; Tumor Necrosis Factor-alpha | 2015 |
[Resveratrol improves high-fat induced nonalcoholic fatty liver in rats].
Topics: AMP-Activated Protein Kinases; Animals; Fatty Liver; Insulin Resistance; Male; Phytotherapy; Rats; Rats, Wistar; Resveratrol; Stilbenes | 2008 |
Resveratrol inhibits nonalcoholic fatty liver disease in rats.
Topics: Animals; Antioxidants; Catalase; Disease Models, Animal; Fatty Liver; Glucose; Glutathione Peroxidase; Lipid Peroxidation; Male; Malondialdehyde; Nitric Oxide Synthase; Oxidative Stress; Random Allocation; Rats; Rats, Wistar; Resveratrol; Severity of Illness Index; Stilbenes; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2008 |
Dietary resveratrol alters lipid metabolism-related gene expression of mice on an atherogenic diet.
Topics: Animals; Antioxidants; Body Weight; Diet, Atherogenic; Eating; Fatty Liver; Gene Expression; Lipid Metabolism; Lipids; Liver; Male; Mice; Mice, Inbred C57BL; Oligonucleotide Array Sequence Analysis; Organ Size; Resveratrol; Stilbenes | 2008 |
Resveratrol inhibits the expression of SREBP1 in cell model of steatosis via Sirt1-FOXO1 signaling pathway.
Topics: Animals; Caloric Restriction; Cell Line, Tumor; Cell Survival; Fatty Liver; Forkhead Box Protein O1; Forkhead Transcription Factors; Humans; Hypolipidemic Agents; Mice; Models, Biological; Palmitic Acid; Resveratrol; Signal Transduction; Sirtuin 1; Sirtuins; Sterol Regulatory Element Binding Protein 1; Stilbenes; Triglycerides | 2009 |
Attenuation of 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity by resveratrol: a comparative study with different routes of administration.
Topics: Administration, Oral; Animals; Antioxidants; Biological Availability; Fatty Liver; Injections, Subcutaneous; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Polychlorinated Dibenzodioxins; Receptors, Aryl Hydrocarbon; Resveratrol; Stilbenes; Toxicity Tests; Wasting Syndrome | 2009 |
Resveratrol improves insulin resistance hyperglycemia and hepatosteatosis but not hypertriglyceridemia, inflammation, and life span in a mouse model for Werner syndrome.
Topics: Animals; Anticarcinogenic Agents; Disease Models, Animal; Fatty Liver; Hyperglycemia; Hypertriglyceridemia; Inflammation; Insulin Resistance; Mice; Mice, Inbred C57BL; Resveratrol; Stilbenes; Werner Syndrome | 2011 |
Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress.
Topics: Acyl-CoA Oxidase; Animals; Antioxidants; Carnitine O-Palmitoyltransferase; Dose-Response Relationship, Drug; Fatty Acids; Fatty Liver; Isoenzymes; Lipid Metabolism; Lipids; Liver; Male; Obesity; Organ Size; Oxidative Stress; Random Allocation; Rats; Rats, Zucker; Resveratrol; Stilbenes; Up-Regulation | 2012 |
Resveratrol attenuates obesity-associated peripheral and central inflammation and improves memory deficit in mice fed a high-fat diet.
Topics: Adipose Tissue; Animals; Anti-Inflammatory Agents, Non-Steroidal; Diet, High-Fat; Fatty Liver; Glucose Tolerance Test; Inflammation; Insulin Resistance; Male; Maze Learning; Memory Disorders; Mice; Obesity; Resveratrol; Stilbenes | 2012 |
Differential effects of low-dose resveratrol on adiposity and hepatic steatosis in diet-induced obese mice.
Topics: Adiposity; Animals; Cholesterol; Diet; Diet, High-Fat; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fatty Acid Synthases; Fatty Liver; Glucosephosphate Dehydrogenase; Hyperlipidemias; Liver; Male; Mice; Mice, Inbred C57BL; Obesity; Phosphatidate Phosphatase; Resveratrol; Stilbenes; Triglycerides; Weight Gain | 2012 |
Resveratrol helps recovery from fatty liver and protects against hepatocellular carcinoma induced by hepatitis B virus X protein in a mouse model.
Topics: Animals; Antineoplastic Agents, Phytogenic; Blotting, Western; Carcinoma, Hepatocellular; Disease Models, Animal; Fatty Liver; Glutathione; Humans; Immunoenzyme Techniques; Liver Neoplasms, Experimental; Liver Regeneration; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stilbenes; Trans-Activators; Tumor Cells, Cultured; Viral Regulatory and Accessory Proteins | 2012 |
Transcriptomic and metabonomic profiling reveal synergistic effects of quercetin and resveratrol supplementation in high fat diet fed mice.
Topics: Animals; Blood Glucose; Carbohydrate Metabolism; Cluster Analysis; Diet, High-Fat; Dietary Supplements; Drug Synergism; Drug Therapy, Combination; Fatty Liver; Gene Expression Profiling; Lipid Metabolism; Lipids; Liver; Male; Metabolome; Metabolomics; Mice; Mice, Inbred C57BL; Molecular Sequence Annotation; Oligonucleotide Array Sequence Analysis; Quercetin; Resveratrol; Stilbenes; Transcriptome | 2012 |
Resveratrol prevents hepatic steatosis induced by hepatitis C virus core protein.
Topics: Adenoviridae; Animals; Blotting, Western; Cells, Cultured; Fatty Liver; Gastrointestinal Agents; Gene Expression Profiling; Genetic Vectors; Hepacivirus; Hepatitis C, Chronic; Hepatocytes; Liver; Mice; Mice, Inbred C57BL; PPAR alpha; Recombinant Proteins; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Sirtuin 1; Stilbenes; Triglycerides; Viral Core Proteins | 2012 |
Resveratrol attenuates oxidative stress and prevents steatosis and hypertension in obese rats programmed by early weaning.
Topics: Animals; Antioxidants; Blood Glucose; Dyslipidemias; Fatty Liver; Female; Glutathione Peroxidase; Hyperphagia; Hypertension; Insulin Resistance; Liver; Obesity; Oxidative Stress; Rats; Rats, Wistar; Resveratrol; Stilbenes; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Weaning | 2013 |
[Effects of resveratrol on the morphology of lipid droplets and the expression of lipid droplet-associated proteins in mouse primary hepatocytes].
Topics: Animals; Carrier Proteins; Cells, Cultured; Dose-Response Relationship, Drug; Fatty Liver; Hepatocytes; Lipid Metabolism; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Perilipin-1; Perilipin-2; Phosphoproteins; Resveratrol; Stilbenes; Triglycerides | 2012 |
Resveratrol up-regulates hepatic uncoupling protein 2 and prevents development of nonalcoholic fatty liver disease in rats fed a high-fat diet.
Topics: Adipose Tissue; Animals; Biomarkers; Blotting, Western; Diet, High-Fat; Dietary Supplements; Disease Models, Animal; Fatty Liver; Ion Channels; Liver; Male; Mitochondrial Proteins; Non-alcoholic Fatty Liver Disease; Rats, Wistar; Real-Time Polymerase Chain Reaction; Resveratrol; RNA, Messenger; RNA, Ribosomal, 18S; Stilbenes; Triglycerides; Uncoupling Protein 2; Up-Regulation | 2012 |
Alleviative effects of resveratrol on nonalcoholic fatty liver disease are associated with up regulation of hepatic low density lipoprotein receptor and scavenger receptor class B type I gene expressions in rats.
Topics: Animals; Energy Metabolism; fas Receptor; Fatty Liver; Gene Expression; Lipid Metabolism; Male; Non-alcoholic Fatty Liver Disease; Rats; Rats, Wistar; Receptors, LDL; Resveratrol; Scavenger Receptors, Class B; Stilbenes; Thyroid Hormone Receptors beta; Weight Gain | 2013 |
Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase.
Topics: Animals; Antioxidants; Cyclic AMP-Dependent Protein Kinases; Diet; Enzyme Activation; Fatty Liver; Glucose Clamp Technique; Humans; Hyperinsulinism; Liver; Male; Rats; Resveratrol; Stilbenes; Triglycerides | 2008 |